Patent ductus arteriousus. Patent ductus arteriousus
Conditions
Interventions
Administer oral ibuprofen(suspension 100 mg/5 ml from Hakim drug company) as 20 mg/kg in first day,10 mg/kg in second day and 10 mg/kg in third day..
Treatment - Drugs
Administer oral ibuprofen(suspension 100 mg/5 ml from Hakim drug company) as 20 mg/kg in first day,10 mg/kg in second day and 10 mg/kg in third day.
Sponsors
Vice chancellor for Research Of Shiraz University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Days to 30 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria: Gestational age 37 weeks or more, age of after birth: 3 to 30 days, patent ductus arteriosus. exclusion criteria: congenital heart disease dependent to patent ductus arteriosus, unable to feeding, bleeding tendency disorder, oliguria, creatinin more than 1.8 mg/dl.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Closure of dutus arteriosus. Timepoint: one day before intervention and one day after end of intervention. Method of measurement: Doppler Echocardiography Vivid 3 ultrasound machine GE vingmed, Horten, Norwey. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects like decrease urine output, gastrointestinal bleeding and discomfort, impaired renal function. Timepoint: one day before intervention, second day of intervention, one day after intervention. Method of measurement: clinical evaluation and check CBC, Creatinin , platelet, urine output. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Mehrdad Rezaei
Shiraz University Of Medical Science
Outcome results
None listed